Forget iSpecimen, Buy These 3 Diagnostic & Research Stocks Instead

This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEB6R0AQ_M.jpg

The diagnostic & research industry is expected to witness an uptrend. Dr. Anthony Fauci recently said that the United States has “the potential to go into a fifth wave” of coronavirus infections amid rising cases and stagnating vaccination rates. This should benefit the diagnostics & research market in the near term. According to a PR Newswire report, the Medical Diagnostics Market is projected to grow by $61.56 billion from 2021 – 2025.

Therefore, we think investors that are looking to benefit from the diagnostics & research industry’s growth could invest in quality stocks Quest Diagnostics Incorporated (NYSE:DGX), QIAGEN N.V. (QGEN), and Global Cord Blood Corporation (CO).

Continue reading on StockNews